NIH RADx Funding NIH RADx Funding US$30M award for COVID-19 diagnostics US National Institutes of Health (NIH) has awarded Ellume US$30million to accelerate the company’s range of COVID-19 antigen tests Learn more Global Partnership Global partnership with QIAGEN for COVID-19 diagnosis Ellume has partnered with global diagnostics company QIAGEN to bring fast, reliable COVID tests to market, addressing the global demand for rapid diagnostic tests. Learn more COVID-19 Response Responding to the COVID-19 global pandemic Ellume is developing next generation diagnostic products to address the current COVID-19 healthcare burden on our global community. Learn more ellume·lab Digital diagnostic device for healthcare professionals Request info ellume lab Logo Offering a suite of fast, accurate diagnostic tests for common illnesses. Learn more We have created the next generation of digital diagnostics Watch Video

We develop, manufacture and commercialise the next generation of digital diagnostic products for clinicians and consumers.


* indicates required